Related Experiment Video
Updated: Jan 24, 2026

ADSC-sheet Transplantation to Prevent Stricture after Extended Esophageal Endoscopic Submucosal Dissection
Published on: February 10, 2017
Delayed Duodenal Ulcer Perforation Following Esophageal Endoscopic Submucosal Dissection Complicated by Perforation:
Shinya Nakatani1, Sayaka Mizuno1, Takahiro Fuji1
1Department of Medicine Division of Gastroenterology, Showa Medical University School of Medicine Tokyo Japan.
None:
Endoscopic submucosal dissection (ESD) is an established treatment of superficial esophageal neoplasms. Common complications include bleeding, perforation, and stricture. However, delayed gastrointestinal perforation distant from the ESD site is exceptionally rare. We report the case of a woman in her 70s with a history of nonsteroidal anti-inflammatory drug (NSAID)-associated duodenal ulcer and Helicobacter pylori infection who underwent ESD for superficial esophageal squamous cell carcinoma. After eradication therapy and 2 months of proton pump inhibitor (PPI) use, both treatments were discontinued. Preoperative endoscopy confirmed a scarred duodenal ulcer. Intraoperative esophageal perforation occurred during ESD and was closed with clips. Postoperative computed tomography (CT) showed mediastinal emphysema without intra-abdominal free air. The patient was treated in high care with fasting and antibiotics, but without PPI therapy. Six days postoperatively, the patient developed acute abdominal pain. CT revealed free air near the duodenal bulb, and emergency endoscopy identified a 10-mm perforated duodenal ulcer at the scarred site. Endoscopic closure was unfeasible, and laparoscopic omental patch repair was performed. PPI therapy was resumed postoperatively, and the patient recovered uneventfully. This case suggests that stress-related mucosal disease may have contributed to duodenal perforation. Background risks included ulcer history and scarring, whereas alleviating factors included no NSAID/steroid exposure, eradicated H. pylori, and absence of infection at the esophageal perforation. Guidelines do not endorse routine PPI use after ESD, and consensus following iatrogenic perforation is lacking. This case suggests that prophylactic PPI therapy may be considered in patients with risk factors such as recent peptic ulcer disease or intraoperative perforation.
Related Concept Videos
Esophageal Perforation-I: Introduction
The location of esophageal perforation can vary, occurring anywhere along the esophagus....
Esophageal Perforation-II: Clinical Manifestations and Management
Clinical Manifestations:
Esophageal Varices-I: Introduction
Peptic Ulcer Disease II: Pathophysiology
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Hemodialysis II: Procedure and Complications
Diabetes: Symptoms, Diagnosis, and Complications

